Publication of Final Terms by Westpac Banking Corporation
The following Final Terms are available for viewing:
Final Terms dated 27 February 2019 relating to Series 1439 CNY150,000,000 Fixed Rate Instruments due March 2024 issued by Westpac Banking Corporation (ABN 33 007 457 141) under its Programme for the Issuance of Debt Instruments.
To view the Final Terms in full, please paste the following URL into the address bar of your browser.
For further information, please contact
Westpac Banking Corporation
23 Camomile Street
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Final Terms and Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus and Final Terms is not addressed. Prior to relying on the information contained in the Base Prospectus and Final Terms you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.
This publication does not constitute an offering of debt instruments (the "Instruments"), and is not for distribution in or into the United States. The Instruments have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), or any relevant securities laws of any state of the United States and, subject to certain exceptions, the Instruments may not be offered, sold or delivered in the United States or to, or for the account or benefit of, U.S. persons, as such terms are defined in Regulation S under the Securities Act. Instruments in bearer form are subject to U.S. tax law requirements and may not be offered, sold or delivered within the United States or its possessions or to a U.S. person, except in certain transactions permitted by U.S. tax regulations. Terms used in the preceding sentence have the meanings given to them by the U.S. Internal Revenue Code and regulations thereunder. There will be no public offering of the Instruments in the United States.
Your right to access this service is conditional upon complying with the above requirement. In particular, your accessing this service will constitute your representation that you are not in the United States and you are not a U.S. person within the meaning of Regulation S under the Securities Act and the U.S. Internal Revenue Code and regulations thereunder.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact email@example.com or visit www.rns.com.